Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases

American Journal of Physiology. Heart and Circulatory Physiology
Bryan T Hackfort, Paras K Mishra

Abstract

Despite an obnoxious smell and toxicity at a high dose, hydrogen sulfide (H2S) is emerging as a cardioprotective gasotransmitter. H2S mitigates pathological cardiac remodeling by regulating several cellular processes including fibrosis, hypertrophy, apoptosis, and inflammation. These encouraging findings in rodents led to initiation of a clinical trial using a H2S donor in heart failure patients. However, the underlying molecular mechanisms by which H2S mitigates cardiac remodeling are not completely understood. Empirical evidence suggest that H2S may regulate signaling pathways either by directly influencing a gene in the cascade or interacting with nitric oxide (another cardioprotective gasotransmitter) or both. Recent studies revealed that H2S may ameliorate cardiac dysfunction by up- or downregulating specific microRNAs. MicroRNAs are noncoding, conserved, regulatory RNAs that modulate gene expression mostly by translational inhibition and are emerging as a therapeutic target for cardiovascular disease (CVD). Few microRNAs also regulate H2S biosynthesis. The inter-regulation of microRNAs and H2S opens a new avenue for exploring the H2S-microRNA crosstalk in CVD. This review embodies regulatory mechanisms that maintain the p...Continue Reading

References

Sep 15, 1980·Biochemical Pharmacology·T C BartholomewC G Curtis
Feb 24, 2000·The Journal of Pathology·D L Carden, D N Granger
Nov 6, 2001·Cellular and Molecular Life Sciences : CMLS·P VendittiS Di Meo
May 22, 2002·Circulation·Subodh VermaTerrence M Yau
Jun 11, 2002·Biochemical and Biophysical Research Communications·Ko EtoHideo Kimura
Feb 10, 2006·Journal of Applied Physiology·Charles W LefflerRui Wang
Aug 17, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Renata C O ZanardoJohn L Wallace
Sep 14, 2006·Annual Review of Pharmacology and Toxicology·Thomas W KenslerShyam Biswal
May 1, 2007·Nature Medicine·Alessandra CarèGianluigi Condorelli
May 19, 2007·Science·Philipp KapranovThomas R Gingeras
Sep 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·John W ElrodDavid J Lefer
Oct 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Gloria A BenavidesDavid W Kraus
Jan 15, 2008·Cell·Beth Levine, Guido Kroemer
Apr 18, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Nathan L WhitfieldKenneth R Olson
Aug 30, 2008·Antioxidants & Redox Signaling·Mari IshigamiHideo Kimura
Nov 15, 2008·Journal of Molecular and Cellular Cardiology·Xiaoqing HeQiang Ma
Feb 26, 2009·Cell·Chris P PontingWolf Reik
Mar 17, 2009·Biochimica Et Biophysica Acta·Daniele MancardiPasquale Pagliaro
Mar 27, 2009·Journal of Cellular and Molecular Medicine·Paras Kumar MishraSuresh C Tyagi
May 9, 2009·British Journal of Pharmacology·Michael A InskoCsaba Szabo
Jun 10, 2009·International Heart Journal·Yehua TangGaozhong Huang
Jul 17, 2009·Journal of Biochemistry·Norihiro ShibuyaHideo Kimura
Jul 18, 2009·Circulation Research·John W CalvertDavid J Lefer
Sep 23, 2009·Antioxidants & Redox Signaling·David R LindenJoseph H Szurszewski
Sep 23, 2009·Antioxidants & Redox Signaling·John W CalvertDavid J Lefer
Dec 17, 2009·Diabetes/metabolism Research and Reviews·Biao FengSubrata Chakrabarti
May 14, 2010·Journal of Medicinal Chemistry·Giuseppe CaliendoJohn L Wallace
Jun 23, 2010·British Journal of Clinical Pharmacology·Christopher F ToombsCsaba Szabo
Jun 26, 2010·Journal of Hypertension·Johanna SchleifenbaumMaik Gollasch
Jul 2, 2010·British Journal of Pharmacology·Edward A WintnerCsaba Szabo

❮ Previous
Next ❯

Citations

Dec 13, 2016·International Journal of Molecular Sciences·Ángela L Riffo-CamposPriscilla Brebi-Mieville
Jan 9, 2018·Endocrine Reviews·Abraham S MeijnikmanHilde Herrema
Jan 10, 2019·Scandinavian Journal of Gastroenterology·Michał ŻorniakMarek Hartleb
Mar 30, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Sumit KarParas K Mishra
Apr 23, 2019·Experimental and Therapeutic Medicine·Jianping LiuQinghong Cheng
Aug 31, 2019·Analytical and Bioanalytical Chemistry·Xiangpeng LinFangong Kong
Jul 22, 2018·Essays in Biochemistry·María Alcázar-FabraGloria Brea-Calvo
Nov 10, 2020·Journal of Cardiovascular Pharmacology·Peng ZhangZhinong Wang
Dec 15, 2020·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Elena FausteCarlos Bocos
Jun 18, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yuankun ZhaiNeetu Tyagi
Nov 12, 2021·Bioorganic & Medicinal Chemistry Letters·Simon D P BaughMarilyn Schuman Jorns

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis